EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Trends in radiotherapy fractionation for bone metastases: a multi-center study of practice patterns before, during, and after COVID-19

Ellis Slotman, Heidi P Fransen, Roxanne Gal, Joanne M van der Velden, Enja J Bantema-Joppe, Janine G H van Nes, Inge Compter, Judi N A van Diessen, Mirjam E Mast, Paulien G Westhoff, Eva Versteijne, Kim Wortel und 3 weitere

Radiation Oncology Journal · 30.06.2026 · 44 (2) · 107-116

DOI: 10.3857/roj.2026.00038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Oncology Journal, erschienen am 30.06.2026. Verfasst von Ellis Slotman und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Technology and Services Research, University of Twente, Technical Medical Centre, Enschede, the Netherlands. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Trials show similar pain outcomes for hypofractionated and multi-fraction regimens in bone metastases, yet clinical adoption of hypofractionation remains limited. The coronavirus disease 2019 (COVID-19) pandemic may have increased hypofractionation to minimize hospital visits and optimize resources. This study evaluated fractionation patterns before, during and after COVID-19 and compared pain outcomes between regimens in routine practice.Materials and methods: Data on treatment regimens for bone metastases between 2018 and 2022 were collected from 11 of 22 Dutch radiotherapy departments. Trends in utilization of hypofractionated (1–2 times 8 Gy) and multi-fraction (≥5 fractions) regimens were analyzed. For a subset of patients (n = 278), self-reported pain scores were collected at baseline, 4 and 8 weeks, and 3 months. Pain scores and pain response were compared for hypofractionated and multiple-fraction regimens, with complete (pain score 0) or partial (reduction ≥2 points) response classified as responders.

Results

A total of 17,336 patients were included, receiving 31,677 treatment regimens. The majority of the regimens were hypofractionated (n = 25,790, 81%). The use of hypofractionated regimens ranged from 34% to 99% between radiotherapy departments. A statistically significant increase in hypofractionated regimens was observed since the onset of the COVID-19 pandemic in 2020 (p < 0.001). In an exploratory analysis of patients with available pain scores, pain response in the three months post-treatment did not differ significantly between hypofractionated and multi-fraction regimens (56% vs. 63%, p = 0.406).

Conclusion

This study demonstrates a high adoption of hypofractionated regimens, with a slight increase since the COVID-19 pandemic, though considerable variation remains between departments. Pain outcomes were comparable between hypofractionated and multi-fraction regimens, suggesting equal palliation and less treatment burden with hypofractionation.

Schlagwörter

Stichwörter der Autor:innen

COVID-19PainPalliative careRadiation dose hypofractionation

Autor:innen und Institutionen

  • Department of Health Technology and Services Research, University of Twente, Technical Medical Centre, Enschede, the Netherlands.
  • Department of Research and Development, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands.
  • Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
  • Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, the Netherlands.
  • Department of Radiation Oncology, Radiotherapeutisch Instituut Friesland, Leeuwarden, the Netherlands.
  • Department of Radiation Oncology (Maastro), GROW Research Institute for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands.

Zitieren

APA

Slotman, E., Fransen, H. P., Gal, R., van der Velden, J. M., Bantema-Joppe, E. J., van Nes, J. G. H., Compter, I., van Diessen, J. N. A., Mast, M. E., Westhoff, P. G., Versteijne, E., Wortel, K., de Wee, E., Raijmakers, N. J. H., & van der Linden, Y. M. (2026). Trends in radiotherapy fractionation for bone metastases: a multi-center study of practice patterns before, during, and after COVID-19. Radiation Oncology Journal, 44(2), 107-116. https://doi.org/10.3857/roj.2026.00038

Vancouver

Slotman E, Fransen HP, Gal R, van der Velden JM, Bantema-Joppe EJ, van Nes JGH, et al. Trends in radiotherapy fractionation for bone metastases: a multi-center study of practice patterns before, during, and after COVID-19. Radiation Oncology Journal. 2026;44(2):107-116. doi:10.3857/roj.2026.00038

BibTeX
@article{Slotman2026,
  author = {Slotman, Ellis and Fransen, Heidi P and Gal, Roxanne and van der Velden, Joanne M and Bantema-Joppe, Enja J and van Nes, Janine G H and Compter, Inge and van Diessen, Judi N A and Mast, Mirjam E and Westhoff, Paulien G and Versteijne, Eva and Wortel, Kim and de Wee, Eva and Raijmakers, Natasja J H and van der Linden, Yvette M},
  title = {Trends in radiotherapy fractionation for bone metastases: a multi-center study of practice patterns before, during, and after COVID-19},
  journal = {Radiation Oncology Journal},
  year = {2026},
  volume = {44},
  number = {2},
  pages = {107--116},
  doi = {10.3857/roj.2026.00038}
}
Kostenlos starten →